COPD in the general population: prevalence, incidence and survival.
about
The Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary DiseaseGlobal and regional estimates of COPD prevalence: Systematic review and meta-analysisThe association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysisObstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam StudyEpidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region, RussiaEvaluation of malnutrition detected with the Nutritional Risk Screening 2002 (NRS-2002) and the quality of life in hospitalized patients with chronic obstructive pulmonary diseaseCall to action: improving primary care for women with COPD.Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction studyPrevalence and associated factors of COPD among Aboriginal peoples in Canada: a cross-sectional study.Development and validation of a model to predict the 10-year risk of general practitioner-recorded COPD.Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.Continuity in different care modes and its relationship to quality of life: a randomised controlled trial in patients with COPDThe analyses of risk factors for COPD in the Li ethnic group in Hainan, People's Republic of China.Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study.The association of renin-angiotensin system blockades and pneumonia requiring admission in patients with COPD.The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis.The Role of Vascular Endothelial Growth Factor in Small-airway Remodelling in a Rat Model of Chronic Obstructive Pulmonary Disease.Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol.A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction.Socioeconomic Effects of Chronic Obstructive Pulmonary Disease from the Public Payer's Perspective in Poland.Peptidylarginine deiminase 4 promotes age-related organ fibrosisResveratrol inhibits hypoxia-induced proliferation and migration of pulmonary artery vascular smooth muscle cells by inhibiting the phosphoinositide 3-kinase/protein kinase B signaling pathway.Extracorporeal Respiratory Support With a Miniature Integrated Pediatric Pump-Lung Device in an Acute Ovine Respiratory Failure ModelChronic obstructive pulmonary disease is not a risk factor for polyneuropathy: A prospective controlled study.Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan.Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure.Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort.Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.Quantitative Computed Tomography (CT) Assessment of Emphysema in Patients with Severe Chronic Obstructive Pulmonary Disease (COPD) and its Correlation with Age, Sex, Pulmonary Function Tests, BMI, Smoking, and Biomass Exposure.Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies.Matching Inhaler Devices with Patients: The Role of the Primary Care Physician.Misuse of inhalers among COPD patients in a community hospital in Taiwan.Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort studyCombined Effect of Smoking and Occupational Exposure to Dusts, Gases or Fumes on the Incidence of COPDLifetime risk of hospital diagnosed chronic obstructive pulmonary disease in remote Aboriginal people: a cohort study
P2860
Q26771902-E739CD7C-9039-4269-9329-7FEC26D1BEE0Q26772278-A2A431AA-C578-4202-BB96-CBC48E3C1DA2Q28070325-F456F940-1C5F-424D-B471-6D8200E06B02Q28387680-8ADDB715-74F1-4E10-918C-4345261A80B1Q28387926-BCF8135B-AA21-4AAB-93E4-DAA9C557B4F1Q28388092-EEB9E89C-56BF-420C-8D5F-45C1B7B4B390Q33554553-6C539014-FA29-46D6-8C05-ECBD74B3BC1EQ33697705-C0A610EC-D0AB-47A3-A4BD-88037BDDCF5FQ33698652-1312117F-33E9-4A8C-9B9F-BD210BEA16BEQ33884398-CC4DFF03-3F42-4BDD-9012-6EF006583F8DQ35216007-729DCCD8-E8F3-414D-AB82-A87543FCD3DFQ35892527-A42A23ED-9970-44AD-8270-167F09C66991Q35990684-643DF1E8-2909-4C0E-A194-0AFEAC9C6A75Q36347816-DBED5164-131F-49B8-B18E-B6D6176F63CBQ36692766-9618CF85-FDBF-4C45-99C2-5F796D0C6CD0Q36713055-7FC68FF0-0CCE-4ABA-A8FD-075D59B0E427Q37259422-B772C1BE-BEE7-4D44-8C58-436443FC8B94Q37365510-708D85EF-7579-4896-9AE1-93981EEBF66CQ37602044-42254BE7-FEC0-4B83-8B34-A58EDCA19A65Q38352425-E94E4CBB-40C8-40D2-8057-2A871EFD9B50Q39742481-AE481A52-7846-469F-B4B6-1FB326AF88A5Q40072069-835B03EF-1BD0-43E8-82C7-26B306435935Q42323494-12B36936-EB55-4446-A07C-B0B5CAB0C8D7Q42347163-3650FF94-6376-47B8-B7B8-FBFE6AF5708BQ42707198-96C2571E-4A95-4857-B6BB-54C7A9D8A729Q47146553-12DCCA74-60F3-41BA-AFB2-E0E457103ED9Q47655268-0600A7F0-49A2-48E1-B8D9-30B75FA06FC2Q47782851-3F8493FC-15B3-4386-BE37-3DAAA64D7C00Q49963482-BE598AA3-C434-4A34-AA3B-5DE09632574DQ50112050-5B47EC85-3867-4B64-8008-DDCD4D4CB5C0Q55037780-2AC8764F-97AA-4021-88E2-8E2A6CFCB6A0Q55133367-9E4520D9-4BCC-4FDF-8ABB-6FCBC9551DBEQ55285029-F38BBF69-5CC4-45AE-8B23-D8F047108BB5Q55304932-84D35084-50AA-42D1-95FD-773B1DF91B52Q57212809-D8B5955E-AD9E-4CC3-A761-374AC23ACEF9Q57673379-DD94C865-6C45-45B6-8371-ACD5369FFF2FQ57848548-40C0D2FA-17AB-4803-9CFA-96264ED8A807
P2860
COPD in the general population: prevalence, incidence and survival.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
COPD in the general population: prevalence, incidence and survival.
@en
COPD in the general population: prevalence, incidence and survival.
@nl
type
label
COPD in the general population: prevalence, incidence and survival.
@en
COPD in the general population: prevalence, incidence and survival.
@nl
prefLabel
COPD in the general population: prevalence, incidence and survival.
@en
COPD in the general population: prevalence, incidence and survival.
@nl
P2093
P1433
P1476
COPD in the general population: prevalence, incidence and survival.
@en
P2093
Ana S M Afonso
Guy G O Brusselle
Katia M C Verhamme
Miriam C J M Sturkenboom
P304
P356
10.1016/J.RMED.2011.06.012
P577
2011-08-17T00:00:00Z